April 28 - Day 1 - CT (China Time, GMT+08:00)
- Ivan Lin - Head of Manufacturing and Head of MSAT & ATS, JW Therapeutics
- Wenshi Wang - SVP Tech & Ops, FosunKairos
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: RShah@informaconnectls.com
- Cost drivers in gene therapy development and manufacturing
- Scrap & COGs reduction strategies in gene therapy development and manufacturing
- Beyond approvals; building sustainability and resilience in gene therapy manufacturing
- Anthony Chikere - Director, Vector Process Development, Sangamo Therapeutics, Inc.
In recent years, while innovative therapies using cells have attracted attention, high drug prices have become a dilemma. One of the keys to the advancement of cell therapy products is manufacturing automation through robotics and AI. In this presentation, I will explore global trends in research and development, introduce specific examples of strengthening manufacturing processes, reducing costs, and data driven process optimization, and demonstrate the possibilities for innovation.
- Hideto Yamaguchi - President & CEO, Cellafa Bioscience Inc.